Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

Robert W. Baird's Rating of Abbott Laboratories on 10/22/2026

On October 22, 2026, Robert W. Baird updated its outlook on Abbott Laboratories (NYSE:ABT) with the action "Boost Price Target", setting a price target of $123.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Robert W. Baird

DateCompanyAction
10/22/2026
Biohaven Ltd. stock logo
BHVN
Biohaven
Set Price Target
10/22/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
Boost Price Target
10/22/2026
Wingstop Inc. stock logo
WING
Wingstop
Lower Price Target
10/22/2026
Cencora, Inc. stock logo
COR
Cencora
Boost Price Target
10/22/2026
Danaher Corporation stock logo
DHR
Danaher
Boost Price Target
10/22/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Boost Price Target
More Ratings From Robert W. Baird